Funded Biotechnology Startups in Edinburgh
In the 18 most recent biotech rounds listed for Edinburgh, the largest disclosed amount is EnteroBiotix’s $26M (2026-04-29).
In the 18 most recent biotech rounds listed for Edinburgh, the largest disclosed amount is EnteroBiotix’s $26M (2026-04-29). That $26M round stands out as an outlier above the rest: only one other entry is close at $11M (Cumulus Oncology $11M on 2024-01-08; Wobble Genomics shows $11M on 2024-03-07), while most other disclosed rounds range from $1M to $10M (e.g., Celtic Renewables $10M on 2026-05-05; Bioliberty $8M on 2026-03-18).
The timing is clustered toward the newest half of the window: 3 of the 18 disclosed rounds fall in March–May 2026 (Bioliberty 2026-03-18 $8M; EnteroBiotix 2026-04-29 $26M; Celtic Renewables 2026-05-05 $10M). Stage labels are also mixed, with “Series Unknown” appearing in 11 of the 18 rows (including 2026-04-29 EnteroBiotix $26M and 2026-02-19 Lario Therapeutics $2M), while explicit “Seed” appears 5 times and “Series A” appears once (Bioliberty, 2026-03-18, $8M). Dates span from 2021-07-29 (Macomics, $6M) to 2026-05-05 (Celtic Renewables, $10M).
Most recent rounds
18 shownRelated listings
Frequently asked
What’s the largest disclosed biotech round in this Edinburgh set, and how does it compare to the next-highest disclosed amounts?
EnteroBiotix’s $26M on 2026-04-29 is the largest disclosed round here. The next-highest disclosed amounts are $11M, appearing for both Cumulus Oncology on 2024-01-08 and Wobble Genomics on 2024-03-07, with most remaining rounds between $1M and $10M (for example Celtic Renewables $10M on 2026-05-05 and Bioliberty $8M on 2026-03-18).
Are these Edinburgh biotech rounds concentrated in a specific time window?
Yes, the newest quarter of the list is concentrated in spring 2026: three rows fall in March–May 2026 (Bioliberty $8M on 2026-03-18; EnteroBiotix $26M on 2026-04-29; Celtic Renewables $10M on 2026-05-05). Outside that cluster, there’s still a steady run through 2024 with multiple entries between April and December 2024 (e.g., Calcivis $6M on 2024-04-03; Concinnity Genetics $4M on 2024-12-16).
How much of the stage information is missing or labeled as “Series Unknown”?
“Series Unknown” appears in 11 of the 18 rows. That includes recent rounds like Lario Therapeutics $2M (2026-02-19) and EnteroBiotix $26M (2026-04-29), as well as older entries such as Ingenza $3M (2024-11-26) and Medannex $400K (2024-07-25).
Which stage labels show up more than once in this list, and where?
Seed appears 5 times, including Kynos Therapeutics $9M (2022-04-07), Green Bioactives $3M (2022-12-13), and Cytochroma $1M (2021-12-16). Series A appears once in the displayed rows: Bioliberty $8M on 2026-03-18.
Is there a clear low-end outlier among the smallest disclosed rounds?
Yes. The smallest disclosed amount is Invizius at $1M on 2024-09-23, and there are only a few entries near it (for example Cytochroma $1M on 2021-12-16). Several other sub-$2M rounds sit slightly higher, such as Medannex $400K (2024-07-25) is actually below $1M, making $400K the lowest after checking the disclosed amounts in the rows.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.